-
1
-
-
20444409135
-
Latest advances in understanding pre-eclampsia
-
C.W. Redman, and I.L. Sargent Latest advances in understanding pre-eclampsia Science 308 2005 1592 1594
-
(2005)
Science
, vol.308
, pp. 1592-1594
-
-
Redman, C.W.1
Sargent, I.L.2
-
2
-
-
78650830910
-
Abnormal placentation, angiogenic factors, and the pathogenesis of pre-eclampsia
-
M. Silasi, B. Cohen, S.A. Karumanchi, and S. Rana Abnormal placentation, angiogenic factors, and the pathogenesis of pre-eclampsia Obstet Gynecol Clin North Am 37 2010 239 253
-
(2010)
Obstet Gynecol Clin North Am
, vol.37
, pp. 239-253
-
-
Silasi, M.1
Cohen, B.2
Karumanchi, S.A.3
Rana, S.4
-
5
-
-
0034619029
-
Pre-eclampsia
-
J.J. Walker Pre-eclampsia Lancet 356 2000 1260 1265
-
(2000)
Lancet
, vol.356
, pp. 1260-1265
-
-
Walker, J.J.1
-
6
-
-
0020680678
-
Characterization of catechol-O-methyltransferase activity in human uterine decidua vera tissue
-
M.L. Casey, and P.C. MacDonald Characterization of catechol-O- methyltransferase activity in human uterine decidua vera tissue Am J Obstet Gynecol 145 1983 453 457 (Pubitemid 13138132)
-
(1983)
American Journal of Obstetrics and Gynecology
, vol.145
, Issue.4
, pp. 453-457
-
-
Casey, M.L.1
MacDonald, P.C.2
-
8
-
-
45749098246
-
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia
-
DOI 10.1038/nature06951, PII NATURE06951
-
K. Kanasaki, K. Palmsten, and H. Sugimoto et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia Nature 453 2008 1117 1121 (Pubitemid 351871733)
-
(2008)
Nature
, vol.453
, Issue.7198
, pp. 1117-1121
-
-
Kanasaki, K.1
Palmsten, K.2
Sugimoto, H.3
Ahmad, S.4
Hamano, Y.5
Xie, L.6
Parry, S.7
Augustin, H.G.8
Gattone Jr., V.H.9
Folkman, J.10
Strauss, J.F.11
Kalluri, R.12
-
9
-
-
77956189001
-
Pre-eclampsia: Connecting angiogenic and metabolic pathways
-
V. Shenoy, K. Kanasaki, and R. Kalluri Pre-eclampsia: connecting angiogenic and metabolic pathways Trends Endocrinol Metab 21 2010 529 536
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 529-536
-
-
Shenoy, V.1
Kanasaki, K.2
Kalluri, R.3
-
10
-
-
61349089916
-
Mouse models for pre-eclampsia: Disruption of redox-regulated signaling
-
S. Banerjee, H. Randeva, and A.E. Chambers Mouse models for pre-eclampsia: disruption of redox-regulated signaling Reprod Biol Endocrinol 7 2009 4
-
(2009)
Reprod Biol Endocrinol
, vol.7
, pp. 4
-
-
Banerjee, S.1
Randeva, H.2
Chambers, A.E.3
-
11
-
-
58049195693
-
Low catechol-O-methyltransferase and 2-methoxyestradiol in pre-eclampsia: More than a unifying hypothesis
-
D. Dragun, and A. Haase-Fielitz Low catechol-O-methyltransferase and 2-methoxyestradiol in pre-eclampsia: more than a unifying hypothesis Nephrol Dial Transplant 24 2009 31 33
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 31-33
-
-
Dragun, D.1
Haase-Fielitz, A.2
-
12
-
-
76149146741
-
Pre-eclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions
-
S.B. Lee, A.P. Wong, and K. Kanasaki et al. Pre-eclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions Am J Pathol 176 2010 710 720
-
(2010)
Am J Pathol
, vol.176
, pp. 710-720
-
-
Lee, S.B.1
Wong, A.P.2
Kanasaki, K.3
-
13
-
-
78149272737
-
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection
-
F. Barchiesi, E. Lucchinetti, and M. Zaugg et al. Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection Hypertension 56 2010 964 972
-
(2010)
Hypertension
, vol.56
, pp. 964-972
-
-
Barchiesi, F.1
Lucchinetti, E.2
Zaugg, M.3
-
14
-
-
0036232439
-
Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCS
-
DOI 10.1161/01.HYP.0000013863.25970.BA
-
F. Barchiesi, E.K. Jackson, and D.G. Gillespie et al. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCS Hypertension 39 2002 874 879 (Pubitemid 34437542)
-
(2002)
Hypertension
, vol.39
, Issue.4
, pp. 874-879
-
-
Barchiesi, F.1
Jackson, E.K.2
Gillespie, D.G.3
Zacharia, L.C.4
Fingerle, J.5
Dubey, R.K.6
-
16
-
-
15044344544
-
Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies
-
DOI 10.1136/bmj.38380.674340.E0
-
K. Duckitt, and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 2005 565 567 (Pubitemid 40380349)
-
(2005)
British Medical Journal
, vol.330
, Issue.7491
, pp. 565-567
-
-
Duckitt, K.1
Harrington, D.2
-
17
-
-
0028907886
-
Aging and endothelial function in normotensive subjects and patients with essential hypertension
-
S. Taddei, A. Virdis, and P. Mattei et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension Circulation 91 1995 1981 1987
-
(1995)
Circulation
, vol.91
, pp. 1981-1987
-
-
Taddei, S.1
Virdis, A.2
Mattei, P.3
-
19
-
-
84868153248
-
Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia
-
A. Pérez-Sepúlveda, M.J. Torres, and F.J. Valenzuela et al. Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia Prenat Diagn 32 2012 1053 1058
-
(2012)
Prenat Diagn
, vol.32
, pp. 1053-1058
-
-
Pérez-Sepúlveda, A.1
Torres, M.J.2
Valenzuela, F.J.3
-
20
-
-
84873060035
-
Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction
-
S.O. Jobe, C.T. Tyler, and R.R. Magness Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction Hypertension 61 2013 480 487
-
(2013)
Hypertension
, vol.61
, pp. 480-487
-
-
Jobe, S.O.1
Tyler, C.T.2
Magness, R.R.3
-
21
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia
-
DOI 10.1172/JCI200317189
-
S.E. Maynard, J.Y. Min, and J. Merchan et al. Excess placental soluble Fms-like tyrosine kinase 1 (sFLT1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.5
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.-Y.2
Merchan, J.3
Lim, K.-H.4
Li, J.5
Mondal, S.6
Libermann, T.A.7
Morgan, J.P.8
Sellke, F.W.9
Stillman, I.E.10
Epstein, F.H.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
22
-
-
0038030642
-
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
-
DOI 10.1210/jc.2002-021942
-
K. Koga, Y. Osuga, and O. Yoshino et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with pre-eclampsia J Clin Endocrinol Metab 88 2003 2348 2351 (Pubitemid 36549917)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.5
, pp. 2348-2351
-
-
Koga, K.1
Osuga, Y.2
Yoshino, O.3
Hirota, Y.4
Ruimeng, X.5
Hirata, T.6
Takeda, S.7
Yano, T.8
Tsutsumi, O.9
Taketani, Y.10
-
23
-
-
36448996940
-
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression
-
DOI 10.1161/HYPERTENSIONAHA.107.096594
-
J.S. Gilbert, S.A. Babcock, and J.P. Granger Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble Fms-like tyrosine kinase-1 expression Hypertension 50 2007 1142 1147 (Pubitemid 350172938)
-
(2007)
Hypertension
, vol.50
, Issue.6
, pp. 1142-1147
-
-
Gilbert, J.S.1
Babcock, S.A.2
Granger, J.P.3
-
24
-
-
0025681449
-
Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies
-
R.N. Taylor, M. Varma, N.N. Teng, and J.M. Roberts Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies J Clin Endocrinol Metab 71 1990 1675 1677 (Pubitemid 120032795)
-
(1990)
Journal of Clinical Endocrinology and Metabolism
, vol.71
, Issue.6
, pp. 1675-1677
-
-
Taylor, R.N.1
Varma, M.2
Teng, N.N.H.3
Roberts, J.M.4
-
25
-
-
0026732007
-
Evidence against a pathogenetic role or endothelin in pre-eclampsia
-
A. Benigni, S. Orisio, and F. Gaspari et al. Evidence against a pathogenetic role or endothelin in pre-eclampsia Br J Obstet Gynaecol 99 1992 798 802
-
(1992)
Br J Obstet Gynaecol
, vol.99
, pp. 798-802
-
-
Benigni, A.1
Orisio, S.2
Gaspari, F.3
-
26
-
-
80052038097
-
Endothelin: Key mediator of hypertension in preeclampsia
-
E.M. George, and J.P. Granger Endothelin: key mediator of hypertension in preeclampsia Am J Hypertens 24 2011 964 969
-
(2011)
Am J Hypertens
, vol.24
, pp. 964-969
-
-
George, E.M.1
Granger, J.P.2
-
27
-
-
77950204966
-
Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia
-
K. Matsubara, Y. Matsubara, and S. Hyodo et al. Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia J Obstet Gynaecol Res 36 2010 239 247
-
(2010)
J Obstet Gynaecol Res
, vol.36
, pp. 239-247
-
-
Matsubara, K.1
Matsubara, Y.2
Hyodo, S.3
-
29
-
-
0030909898
-
Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia
-
A.K. Smarason, K.G. Allman, D. Young, and C.W. Redman Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia Br J Obstet Gynaecol 104 1997 538 543 (Pubitemid 27240417)
-
(1997)
British Journal of Obstetrics and Gynaecology
, vol.104
, Issue.5
, pp. 538-543
-
-
Smarason, A.K.1
Allman, K.G.2
Young, D.3
Redman, C.W.G.4
-
30
-
-
0028173273
-
Increased concentrations of dytokines interleukin and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction?
-
I.A. Greer, F. Lyall, and T. Perera et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 84 1994 937 940 (Pubitemid 24360251)
-
(1994)
Obstetrics and Gynecology
, vol.84
, Issue.6
, pp. 937-940
-
-
Greer, I.A.1
Lyall, F.2
Perera, T.3
Boswell, F.4
Macara, L.M.5
-
31
-
-
80054960493
-
Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide
-
C.H. Yeh, W. Chou, and C.C. Chu et al. Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide Shock 36 2011 510 516
-
(2011)
Shock
, vol.36
, pp. 510-516
-
-
Yeh, C.H.1
Chou, W.2
Chu, C.C.3
|